Clinical Trial Update: A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for VX-121 combination therapy in cystic fibrosis notes long-term safety and efficacy monitoring, with the study currently not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• VX-121

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING